Dysregulation of the Excitatory Renal Reflex in the Sympathetic Activation of Spontaneously Hypertensive Rat.

blood pressure hypertension kidney renal reflex sympathetic activity

Journal

Frontiers in physiology
ISSN: 1664-042X
Titre abrégé: Front Physiol
Pays: Switzerland
ID NLM: 101549006

Informations de publication

Date de publication:
2021
Historique:
received: 28 02 2021
accepted: 08 04 2021
entrez: 21 6 2021
pubmed: 22 6 2021
medline: 22 6 2021
Statut: epublish

Résumé

Excessive sympathetic activation plays crucial roles in the pathogenesis of hypertension. Chemical stimulation of renal afferents increases the sympathetic activity and blood pressure in normal rats. This study investigated the excitatory renal reflex (ERR) in the development of hypertension in the spontaneously hypertensive rat (SHR). Experiments were performed in the Wistar-Kyoto rat (WKY) and SHR aged at 4, 12, and 24 weeks under anesthesia. Renal infusion of capsaicin was used to stimulate renal afferents, and thus, to induce ERR. The ERR was evaluated by the changes in the contralateral renal sympathetic nerve activity and mean arterial pressure. At the age of 4 weeks, the early stage with a slight or moderate hypertension, the ERR was more enhanced in SHR compared with WKY. The pressor response was greater than the sympathetic activation response in the SHR. At the age of 12 weeks, the development stage with severe hypertension, there was no significant difference in the ERR between the WKY and SHR. At the age of 24 weeks, the later stage of hypertension with long-term several hypertensions, the ERR was more attenuated in the SHR compared with the WKY. On the other hand, the pressor response to sympathetic activation due to the ERR was smaller at the age of 12 and 24 weeks than those at the age of 4 weeks. These results indicate that ERR is enhanced in the early stage of hypertension, and attenuated in the later stage of hypertension in the SHR. Abnormal ERR is involved in the sympathetic activation and the development of hypertension.

Identifiants

pubmed: 34149454
doi: 10.3389/fphys.2021.673950
pmc: PMC8209386
doi:

Types de publication

Journal Article

Langues

eng

Pagination

673950

Informations de copyright

Copyright © 2021 Ye, Zheng, Wang, Wang, Chen, Li, Kang and Zhu.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Mol Sci. 2017 Aug 02;18(8):
pubmed: 28767097
Cell Death Dis. 2017 Oct 5;8(10):e3074
pubmed: 28981106
Am J Physiol Regul Integr Comp Physiol. 2015 Jan 15;308(2):R79-95
pubmed: 25411364
Hypertension. 2012 Nov;60(5):1280-6
pubmed: 23033372
J Extracell Vesicles. 2019 Dec 2;9(1):1698795
pubmed: 31839907
Am J Physiol Heart Circ Physiol. 2015 May 1;308(9):H1103-11
pubmed: 25637549
Hypertension. 1987 Jan;9(1):69-75
pubmed: 3793202
Am J Physiol Regul Integr Comp Physiol. 2015 Jan 15;308(2):R112-22
pubmed: 25411365
Curr Hypertens Rev. 2019;15(2):144-153
pubmed: 30381083
J Am Soc Hypertens. 2016 May;10(5):457-66
pubmed: 27052349
Cardiovasc Pathol. 2004 Mar-Apr;13(2):71-8
pubmed: 15033155
J Hypertens. 2014 May;32(5):1059-67; discussion 1067
pubmed: 24621806
Neurosci Bull. 2020 May;36(5):463-474
pubmed: 31989424
Pflugers Arch. 2020 Nov;472(11):1577-1586
pubmed: 32915316
Hypertension. 2012 Feb;59(2):367-74
pubmed: 22203749
Hypertension. 2007 Mar;49(3):506-10
pubmed: 17224471
Exp Physiol. 2010 May;95(5):572-80
pubmed: 20304932
Pflugers Arch. 2020 Mar;472(3):325-334
pubmed: 31925527
High Blood Press Cardiovasc Prev. 2014 Jun;21(2):89-105
pubmed: 24789091
Am J Physiol. 1990 Mar;258(3 Pt 2):F606-11
pubmed: 2138422
Gene Ther. 2012 Aug;19(8):810-7
pubmed: 21956687
Front Physiol. 2020 Dec 15;11:601237
pubmed: 33384613
Pain. 1983 Feb;15(2):109-30
pubmed: 6189047
Exp Physiol. 2008 Aug;93(8):945-53
pubmed: 18403445
Prog Cardiovasc Dis. 2021 Mar-Apr;65:76-83
pubmed: 33587963
Nat Rev Nephrol. 2014 Jun;10(6):305-13
pubmed: 24733118
Circ Res. 2015 Mar 13;116(6):976-90
pubmed: 25767284
Neurosci Bull. 2020 Feb;36(2):143-152
pubmed: 31392556
Acta Physiol (Oxf). 2015 Apr;213(4):778-94
pubmed: 25598170
Methods Mol Med. 2005;108:3-15
pubmed: 16028672
Acta Physiol (Oxf). 2017 Jan;219(1):288-304
pubmed: 27214656
Acta Physiol (Oxf). 2017 May;220(1):11-13
pubmed: 28421719
JACC Cardiovasc Interv. 2021 Feb 8;14(3):316-318
pubmed: 33541542
Diabetes Nutr Metab. 2000 Dec;13(6):327-31
pubmed: 11232757
Exp Physiol. 2010 Jan;95(1):51-5
pubmed: 19700514
Am J Physiol Renal Physiol. 2015 Oct 1;309(7):F583-94
pubmed: 26224718
Curr Hypertens Rep. 2016 Sep;18(9):69
pubmed: 27595156
Exp Physiol. 2011 Feb;96(2):94-103
pubmed: 21097645
Hypertension. 2014 Mar;63(3):e25-32
pubmed: 24420544
Am J Physiol. 1989 Aug;257(2 Pt 2):F197-203
pubmed: 2669526
Hypertension. 2007 Nov;50(5):862-8
pubmed: 17909120
Neurosci Bull. 2019 Feb;35(1):1-3
pubmed: 30659525

Auteurs

Chao Ye (C)

Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center of Translational Medicine for Cardiovascular Disease, Department of Physiology, Nanjing Medical University, Nanjing, China.

Fen Zheng (F)

Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center of Translational Medicine for Cardiovascular Disease, Department of Physiology, Nanjing Medical University, Nanjing, China.

Jing-Xiao Wang (JX)

Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center of Translational Medicine for Cardiovascular Disease, Department of Physiology, Nanjing Medical University, Nanjing, China.

Xiao-Li Wang (XL)

Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center of Translational Medicine for Cardiovascular Disease, Department of Physiology, Nanjing Medical University, Nanjing, China.

Qi Chen (Q)

Department of Pathophysiology, Nanjing Medical University, Nanjing, China.

Yue-Hua Li (YH)

Department of Pathophysiology, Nanjing Medical University, Nanjing, China.

Yu-Ming Kang (YM)

Department of Physiology and Pathophysiology, Cardiovascular Research Center, Xi'an Jiaotong University School of Medicine, Xi'an, China.

Guo-Qing Zhu (GQ)

Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center of Translational Medicine for Cardiovascular Disease, Department of Physiology, Nanjing Medical University, Nanjing, China.
Department of Pathophysiology, Nanjing Medical University, Nanjing, China.

Classifications MeSH